Steering Committee

HBPP Steering Committee

The chairmanship is changing every year. If you are interested to join our initiative please contact us via contact [at] hbpp.org.

HBPP Steering Committee

Melanie Föcking, Royal College of Surgeons in Ireland, Dublin | mfocking [at] rcsi.ie

Katrin Marcus, Ruhr University, Bochum | katrin.marcus [at] rub.de

Daniel Martins-de-Souza, University of Campinas, São Paulo | dmsouza [at] unicamp.br

Robert Mccullumsmith, University of Toledo, Toledo | robert.mccullumsmith [at] utoledo.edu

Peter Nilsson, KTH – Royal Institute of Technology, Stockholm | peter.nilsson [at] scilifelab.se

Oliver Schubert, University of Adelaide | oliver.schubert [at] adelaide.edu.au
Charlotte Teunissen, VU University Medical Center Amsterdam | teunissen [at] vumc.nl

Chairs of HBPP

Year(s)	Chair	Co-Chair(s)
2019	Charlotte Teunissen	Oliver Schubert
2018	Oliver Schubert	Katrin Marcus
2017	Katrin Marcus	Charlotte Teunissen
2016	Peter Nilsson	Daniel Martins-de-Souza
2015	Lea T. Grinberg	Katrin Marcus
2013 - 2014	Lea T. Grinberg	Helmut E. Meyer, Young-Mok Park
2011 - 2012	Young-Mok Park	Helmut E. Meyer, Lea T. Grinberg
2009 - 2010	Helmut E. Meyer	Young-Mok Park
2003 - 2008	Helmut E. Meyer	Joachim Klose

Newscorner

Award for Prof. Daniel Martins-de-Souza

Serrapilheira Institute is the first private nonprofit institution created to promote science and increase its visibility and impact in Brazil.
Their first call was directed to identify and support the best young researchers in Brazil. According to its President, Dr. Hugo Aguilaniu, they looked for those who are posing the big questions in their fields.

There were almost 2000 submitted projects, from which they selected 65. These will receive R$ 100,000.00 (near US$ 31,000.00) for one year. The Institute will select 10 to 12 out of the 65 to receive R$ 1 million (near US$ 310,000.00) for additional three years.

Daniel Martins-de-Souza, member of the HBPP steering committee, is one of the 65 awardees. His project uses neuroproteomics to understand the molecular basis of schizophrenia and to identify protein biomarkers in patients' blood which could predict antipsychotic response.